Developing an antituberculosis compounds database and data mining in the search of a motif responsible for the activity of a diverse class of antituberculosis agents

Journal of Chemical Information and Modeling

Volumn 46, Issue 1, 2006, Pages 17-23

  Prakash, Om ^a   Ghosh, Indira ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BACTERIA; DATA MINING; DATABASE SYSTEMS; DRUG DOSAGE; DRUG PRODUCTS;

ANTITUBERCULOSIS; MINIMUM COMMON BIOACTIVE SUBSTRUCTURE (MCBS);

PULMONARY DISEASES;

TUBERCULOSTATIC AGENT;

ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; FACTUAL DATABASE; STRUCTURE ACTIVITY RELATION;

ANTITUBERCULAR AGENTS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33244456408     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050115s     Document Type: Conference Paper

References (18)

1. Stephen, H. Gillespie. MiniReview: Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective. Antimicrob Agents Chemother. 2002, 46 (2), 267-274.
2. World Health Organization. The World Health Organization Global Tuberculosis Program. http://www.who.int/tb/en/
3. Chopra, I.; Hesse, L.; O'Neill, A. J. Exploiting current understanding of antibiotic action for discovery of new drugs. J. Appl. Microbiol. 2002, 92 (Suppl.), 4S-15S.
4. A list of publications from which the database has been created can be made available upon request to the corresponding author.
5. Barry, C. E.; Slayden, R. A.; Sampson, A. E.; Lee, R. E. Use of Genomics and Combinatorial Chemistry in the Development of New Antimycobacterial Drugs. Biochem. Pharmacol. 2000, 59 (3), 221 -231.
6. Tripos Bookshelf and Technical notes. Tripos Inc. 1699 South Hanley, Road St. Louis, (http://www.tripos.com/sciTech/inSilicoDisc/media/LITCTR/DISTILL. PDF)
7. Downs, G. M.; Barnard, J. M. Clustering Methods and Their Uses in Computational Chemistry. Rev. Comput. Chem. 2003, 18, 1-40.
8. Lowis, D. R. HQSAR: A new, Highly Predictive QSAR Technique; Tripos Technical Notes. Tripos Technol. Notes 1997, 1 (5), 1-7.
9. Xue, L.; Godden, J.; Bajorath, J. Database searching for compounds with similar biological activity using short binary bit string representation of molecules. J. Chem. Inf. Comput. Sci. 1999, 39, 881-886
10. Schnur, D. Design and Diversity Analysis of large combinatorial library using cell based methods. J. Chem. Inf. Comput. Sci. 1999, 39, 36-45
11. Knuth, D. E. Sorting and Searching; Addison Wesley: 1973.
12. Seel, M.; Turner, D. B.; Willet, P. Effect of parameter variation in HQSAR. Quant. Struct. - Act. Relat. 1999, 18, 245-252.
13. Cocco, M. T.; Congiu, C.; Onnis, V.; Pusceddu, M. C.; Schivo, M. L.; De Logu, A. Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur. J. Med. Chem. 1999, 34 (12), 1071-1076.
14. Yew,W. W.; Piddock, L. J.; Li, M. S.; Lyon, D.; Chan, C. Y.; Cheng, A. F. Antimycobacterial Activities of Novel Levofloxacin Analogues. Antimicrob. Agents Chemother. 2000, 44 (4), 2126-2129.
15. Khasnobis, S.; Escuyer, V. E.; Chatterjee, D. Emerging therapeutic targets in tuberculosis: Post-genomic era. Expert Opin. Ther. Targets 2002, 6 (1), 21-40.
16. Biava, M.; Fioravanti, R.; Porretta, G. C.; Deidda, D.; Maullu, C.; Pompei, R. New Pyrrole derivatives as antimycobacterial agents analogues of BM212. Bioorg. Med. Chem. Lett. 1999, 9, 2983-2988.
17. Zurenko, G. E.; Yagi, B. H.; Schaadt, R. D.; Allison, J. W.; Kilburn, J. O.; Glickman, S. E.; Hutchinson, D. K.; Barbachyn, M. R.; Brickner, S. J. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 1996, 40 (4), 839-845.
18. Manetti, F.: Corelli, F.; Biava, M.; Fioravanti, R.; Porretta, G. C.; Botta, M. Building a pharmacophore model for a novel class of antitubercular compounds. IL Farmco. 2000, 55 (6-7), 484-491.